San Francisco Biotechnology Network | Bay Area Life Science News, Jobs & Events
  • Home
  • About
  • News
    • SFBN Trending & Featured News & Jobs
  • SFBN Jobs
    • Submit a Job
  • Subscribe
  • Contact
News Ticker
  • [ January 31, 2023 ] Scientist, Immuno-Oncology – Eureka Therapeutics – Emeryville, CA San Francisco Biotech Jobs
  • [ January 31, 2023 ] Town Hall Ventures’ Andy Slavitt on how to invest in Medicaid and health tech News
  • [ January 31, 2023 ] Scientist I (CMC) – Exelixis, Inc. – Alameda, CA San Francisco Biotech Jobs
  • [ January 31, 2023 ] West Coast Territory Manager (BioTech Company – PHD in Biology Preferred) – VectorBuilder Inc. – San Francisco Bay Area, CA San Francisco Biotech Jobs
  • [ January 31, 2023 ] Senior Scientist – Bio-Rad Laboratories, Inc. – Hercules, CA San Francisco Biotech Jobs
HomeNewsSTAT+: Medicare Advantage-focused Oak Street, Agilon Health chart out growth at J.P. Morgan

STAT+: Medicare Advantage-focused Oak Street, Agilon Health chart out growth at J.P. Morgan

January 10, 2023 San Francisco Biotechnology Network News News Comments Off on STAT+: Medicare Advantage-focused Oak Street, Agilon Health chart out growth at J.P. Morgan
Medicare Advantage providers Oak Street & Agilon Health chart out ambitious growth on day one of #JPM23.

Click to view original post

  • Business
  • finance
  • hospitals
  • Insurance
  • Medicare
  • physicians
  • STAT+
Previous

STAT+: New Biogen CEO: New drug launches, more cost cuts, but no ‘radical left turns’ needed

Next

Complex Model Manager – 23andMe – South San Francisco, CA

Related Articles

No Picture
News

Prosecutors: Convicted CEO Elizabeth Holmes is a flight risk

January 21, 2023 San Francisco Biotechnology Network News News Comments Off on Prosecutors: Convicted CEO Elizabeth Holmes is a flight risk

Disgraced Theranos CEO Elizabeth Holmes booked a 2022 flight to Mexico without a scheduled return trip, prompting prosecutors to warn she poses a flight risk while appealing her conviction for… […]

No Picture
News

STAT+: Pharmalittle: Drugmaker raises price of old chemo med 10-fold amid shortages; Alnylam cites drug-price law in halting trial

October 28, 2022 San Francisco Biotechnology Network News News Comments Off on STAT+: Pharmalittle: Drugmaker raises price of old chemo med 10-fold amid shortages; Alnylam cites drug-price law in halting trial

Amid sporadic shortages of a cancer drug, one manufacturer is selling its medicine for 10 to 20 times the prices offered by the only other suppliers. […]

No Picture
News

STAT+: ‘If this works, it changes everything’: Altos Labs founders lay out plan to reverse disease

November 15, 2022 San Francisco Biotechnology Network News News Comments Off on STAT+: ‘If this works, it changes everything’: Altos Labs founders lay out plan to reverse disease

“The idea of reversing disease is not part of the lexicon of physicians, because the idea of reversing disease is tantamount to reversing time.” […]

POST A JOB

Featured Jobs

Follow Us On Twitter

Tweets by @sdbn

Networking & Associations

  • AWIS-SF
  • Bay Area Society for Neuroscience
  • BioScience Forum
  • California Life Sciences Association
  • Meetup: Bay Area Life Tech
  • Meetup: East Bay Bio Network
  • Meetup: San Francisco Biotechnology Meetup
  • Meetup: San Francisco Life Science Professionals
  • Parenteral Drug Association West Coast Chapter
  • SynBioBeta
  • Women in Bio San Francisco

Copyright © 2022 Biotech Networks, LLC

Get Biotech Networks Briefs in Your Inbox: Trending News & Featured Jobs